Literature DB >> 3540146

Tumour microcirculation as a target for hyperthermia.

H S Reinhold, B Endrich.   

Abstract

A great number of investigators have, independently, shown that tumour blood flow is affected by a hyperthermic treatment to a larger extent than normal tissue blood flow. While the majority of the studies on experimental tumours show a decrease and even a lapse in blood flow within the microcirculation during or after hyperthermia, the data on human tumours are less conclusive. Some of the investigators do not find a decrease in circulation, while others do. Obviously, this is an important field of investigation in the clinical application of hyperthermia because a shut down of the circulation would not only facilitate tumour heating (by reducing venous outflow, this reducing the 'heat clearance' from the tumour), but would also facilitate tumour cell destruction. The same holds for alterations that occur subsequently to the circulatory changes, like a heat-induced decrease of tissue pO2 and pH. If the frequently reported circulatory collapse of the tumour circulation could selectively be stimulated by, e.g. acidification or by vasoactive agents, hyperthermic treatment of patients would possibly be greatly facilitated and intensified. In hyperthermic tumour therapy a number of complex processes and interactions takes place, especially when the treatment is performed in combination with radiation therapy. One of them represents the group of processes related to the random probability of cell sterilization of individual tumour cells resulting in exponential survival curves which are typically evaluated with e.g. cell survival assays. This aspect has not been the issue of this paper. The other group of processes deals with the heat-induced changes in the micro-physiology of tumours and normal tissues which, as discussed before, may not only enhance the exponential cell kill, but which may also culminate in vascular collapse with the ensuing necrosis of the tumour tissue in the areas affected. If this takes place, a process of bulk killing of tumour cells results, rather than the random type of cell sterilization. At present it is not clear to what extent the various separate mechanisms contribute to the total effect of tumour control. With all these considerations in mind, one should be aware of the fact that effects, secondary to heat-induced vascular stasis alone will never be efficient enough to eliminate all tumour cells, even though a heat reservoir is created. This is so because some malignant cells will inevitably have already infiltrated normal, surrounding structures and will therefore not be affected by changes in the tumour vascular bed.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3540146     DOI: 10.3109/02656738609012389

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  25 in total

1.  Yellow dye laser thermotherapy of choroidal neovascularisation in age related macular degeneration.

Authors:  M R Beintema; J A Oosterhuis; F Hendrikse
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

2.  A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance.

Authors:  Ardith W El-Kareh; Timothy W Secomb
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

Review 3.  Clinical applications of imaging biomarkers. Part 3. The neuro-oncologist's perspective.

Authors:  A Shenoy
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

4.  Dynamic modeling of photothermal interactions for laser-induced interstitial thermotherapy: parameter sensitivity analysis.

Authors:  S C Jiang; X X Zhang
Journal:  Lasers Med Sci       Date:  2005-11-19       Impact factor: 3.161

Review 5.  Interstitial laser thermotherapy in neurosurgery: a review.

Authors:  T Menovsky; J F Beek; M J van Gemert; F X Roux; S G Bown
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 6.  InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity.

Authors:  Feifan Zhou; Xiaosong Li; Mark F Naylor; Tomas Hode; Robert E Nordquist; Luciano Alleruzzo; Joseph Raker; Samuel S K Lam; Nan Du; Lei Shi; Xiuli Wang; Wei R Chen
Journal:  Cancer Lett       Date:  2015-01-26       Impact factor: 8.679

7.  Metallic Nanoparticles for Cancer Immunotherapy.

Authors:  Emily Reiser Evans; Pallavi Bugga; Vishwaratn Asthana; Rebekah Drezek
Journal:  Mater Today (Kidlington)       Date:  2017-12-14       Impact factor: 31.041

8.  Tumour pO2 can be increased markedly by mild hyperthermia.

Authors:  K Iwata; A Shakil; W J Hur; C M Makepeace; R J Griffin; C W Song
Journal:  Br J Cancer Suppl       Date:  1996-07

9.  Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro.

Authors:  J Wojta; M Holzer; P Hufnagl; G Christ; R L Hoover; B R Binder
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

10.  Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry.

Authors:  Xiaorong Sun; Xiao-Feng Li; James Russell; Ligang Xing; Muneyasu Urano; Gloria C Li; John L Humm; C Clifton Ling
Journal:  Radiother Oncol       Date:  2008-06-05       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.